BBL
RMD icon

Beck Bode LLC’s ResMed RMD Stock Holding History

Beck Bode LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,686
Closed -$5.66M – 111
2025
Q3 		$5.66M Hold
20,686
– – 0.91% 37
2025
Q2 		$5.34M Buy
+20,686
New +$4.93M 0.9% 36
2021
Q3 		– Sell
-219
Closed -$54K – 258
2021
Q2 		$54K Buy
+219
New +$46K 0.01% 125
2020
Q4 		– Sell
-142
Closed -$24K – 221
2020
Q3 		$24K Buy
+142
New +$26.2K 0.01% 155
2020
Q1 		– Sell
-23,450
Closed -$3.63M – 73
2019
Q4 		$3.63M Sell
23,450
-423
-2% -$61K 1.49% 27
2019
Q3 		$3.23M Buy
23,873
+1,815
+8% +$238K 1.42% 28
2019
Q2 		$2.69M Buy
+22,058
New +$2.44M 1.2% 34

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Beck Bode LLC's RMD Position: Q4 2025 in Review

Beck Bode LLC sold out of ResMed (RMD) in Q4 2025, closing a stake of 20,686 shares — an estimated $5.66M sold.

Beck Bode LLC first reported a position in RMD in Q2 2019 and held it in 7 quarters. The position peaked at $5.66M in Q3 2025. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Beck Bode LLC reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Beck Bode LLC sold 20,686 ResMed shares in Q4 2025, an estimated $5.66M.
  • Beck Bode LLC first reported a position in ResMed in Q2 2019 and held it in 7 quarters.
  • Beck Bode LLC's ResMed position peaked at $5.66M in Q3 2025.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Beck Bode LLC's 13F filing for Q4 2025, filed 9 Feb 2026.